Table of Contents

January 01, 2024; Volume 91,Issue 1

From the Editor

  • It’s a new year, looking back and looking forward
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine January 2024, 91 (1) 15-16; DOI: https://doi.org/10.3949/ccjm.91b.01024

    Reflections on highlights from 2023 and impending changes in 2024, along with some acknowledgments and farewells.

The Clinical Picture

  • Conjunctival petechiae in infective endocarditis
    Akinori Sekizawa, MD, Ayaka Nagano, MD, Kenichi Hashimoto, MD, PhD and Yosuke Ono, MD, PhD
    Cleveland Clinic Journal of Medicine January 2024, 91 (1) 20-21; DOI: https://doi.org/10.3949/ccjm.91a.23041

    A 75-year-old-man presented with a 33-day history of intermittent nocturnal fevers of 39°C (102°F) and truncal rashes. The rashes appeared on the same day as the fever.

Review

  • Consumer-grade wearable cardiac monitors: What they do well, and what needs work
    Consumer-grade wearable cardiac monitors: What they do well, and what needs work
    Abdilahi Mohamoud, MBBS, Joseph Jensen, MD and Kevin G. Buda, DO
    Cleveland Clinic Journal of Medicine January 2024, 91 (1) 23-29; DOI: https://doi.org/10.3949/ccjm.91a.23030

    The authors review common consumer-grade wearables, including the accuracy of these monitors compared with medical-grade devices, and present an approach to managing rate or rhythm abnormalities identified on at-home monitoring.

Editorial

  • Wearable cardiac monitors: Where do we stand?
    Jakub Sroubek, MD, PhD
    Cleveland Clinic Journal of Medicine January 2024, 91 (1) 31-32; DOI: https://doi.org/10.3949/ccjm.91a.23081

    Wearable monitors perform well as screening tools for atrial fibrillation, but questions remain: Can they help with stroke prevention, what is their role in patients with known atrial fibrillation, and how do we streamline interpretation?

Review

  • Gastric intestinal metaplasia and gastric cancer prevention: Watchful waiting
    Shrouq Khazaaleh, MD, Mohammad Alomari, MD, Mamoon Ur Rashid, MD, Daniel Castaneda, MD and Fernando J. Castro, MD
    Cleveland Clinic Journal of Medicine January 2024, 91 (1) 33-39; DOI: https://doi.org/10.3949/ccjm.91a.23015

    Malignancy develops in only a small minority of patients with gastric intestinal metaplasia. Recognition of clinical, endoscopic, and histologic features linked with cancer development is critical to identifying patients who require endoscopic surveillance.

  • 2023 Update in ambulatory general internal medicine
    Jason T. Alexander, MD, Simran K. Singh, MD, Sachin D. Shah, MD, Brianna Lambert, MD and Jeremy P. Smith, MD
    Cleveland Clinic Journal of Medicine January 2024, 91 (1) 40-46; DOI: https://doi.org/10.3949/ccjm.91a.23056

    Topics reviewed include prevention of chronic kidney disease progression, diet for preventing secondary cardiovascular disease, prevention of kidney-stone recurrence, drug therapy for weight loss, and cholesterol management.

1-Minute Consult

  • When should we consider SGLT-2 inhibitors in patients with acute decompensated heart failure?
    Osamah Z. Badwan, MD, Lorenzo Braghieri, MD, Warren Skoza, MD, Ankit Agrawal, MD, Venu Menon, MD and W. H. Wilson Tang, MD
    Cleveland Clinic Journal of Medicine January 2024, 91 (1) 47-51; DOI: https://doi.org/10.3949/ccjm.91a.23034

    Evidence from clinical trials supports starting these medications as early as possible in patients hospitalized with acute decompensated heart failure who do not have clear contraindications to them.

Current Drug Therapy

Letter to the Editor

Back to top

In this issue

Jump to